- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
FDA clears Bennett M-DSI system
Bennett X-Ray has joined the ranksof vendors offering digital spot mammography devices. The Foodand Drug Administration last week issued 510(k) marketing clearanceto Bennett's M-DSI product, and Bennett is ready to begin shippingthe device, according to
Bennett X-Ray has joined the ranksof vendors offering digital spot mammography devices. The Foodand Drug Administration last week issued 510(k) marketing clearanceto Bennett's M-DSI product, and Bennett is ready to begin shippingthe device, according to director of sales and marketing GradyMiars.
M-DSI retrofits to Bennett's Contour mammography system andis based on a charge-coupled device (CCD) camera and fiber-opticcoupling technology (SCAN 6/15/94). It was developed by Copiague,NY-based Bennett in coordination with aerospace firm NorthropGrumman.
M-DSI will compete with digital spot mammography products fromLorad and Fischer Imaging. In addition, all three vendors planto highlight their work in full-breast digital imaging at theupcoming Radiological Society of North America meeting.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
